50mg of ipragliflozin

2 trials

Sponsors

Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Kimitsu Chuo Hospital, Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Kimitsu Chuo Hospita

Conditions

type 1 diabetes mellitus

Unknown Phase

Assessing patient satisfaction following treatment with sodium glucose co-transporter 2 inhibitor for type 1 diabetes mellitus

Active, not recruitingJPRN-UMIN000040487

Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Kimitsu Chuo Hospitaltype 1 diabetes mellitus

Start: 2019-03-26Target: 25Updated: 2026-06-29

Assessing patient body composition following treatment with sodium glucose co-transporter 2 inhibitor for type 1 diabetes mellitus

Active, not recruitingJPRN-UMIN000042407

Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Kimitsu Chuo Hospitatype 1 diabetes mellitus

Start: 2019-03-26Target: 25Updated: 2026-06-29

Related Papers

Effects of Sodium Glucose Co-Transporter 2 Inhibitors in Type 1 Diabetes Mellitus on Body Composition and Glucose Variabilities: Single-Arm, Exploratory Trial

Diabetes Therapy2021-03-189 citations

Assessing Patient Satisfaction Following Sodium Glucose Co-Transporter 2 Inhibitor Treatment for Type 1 Diabetes Mellitus: A Prospective Study in Japan.

2020-11-258 citations